Echocardiographic Diagnosis and Hemodynamic Evaluation of Patent Ductus Arteriosus in Extremely Low Gestational Age Newborn (ELGAN) Infants

Echocardiographic Diagnosis and Hemodynamic Evaluation of Patent Ductus Arteriosus in Extremely Low Gestational Age Newborn (ELGAN) Infants

Persistent Patent ductus arteriosus (PDA) is a common finding in extremely low gestational age newborn infants and its prevalence is inversely proportional to the gestational age. The presence of a persistent PDA is associated with increased mortality and several significant morbidities including in...

Full description

Bibliographic Details
Main Authors:	Yogen Singh, Alain Fraisse, Omer Erdeve, Begum Atasay
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2020-11-01
Series:	Frontiers in Pediatrics
Subjects:	patent ductus arteriosus (PDA) extreme preterm infants clinical decision making echocardiographic evaluation of PDA ELGAN extremely low gestational age newborn
Online Access:	https://www.frontiersin.org/articles/10.3389/fped.2020.573627/full

Similar Items

Transcatheter Closure of Patent Ductus Arteriosus in Infants With Weight Under 1,500 Grams
by: Alain Fraisse, et al.
Published: (2020-09-01)

Prophylaxis of Patent Ductus Arteriosus with Paracetamol in Extremely Low Gestational Age Newborns (ELGANs): A Single-Institution Observational Study in Vietnam
by: Tinh Thu Nguyen, et al.
Published: (2023-12-01)

Personalized Evidence-Based Management of Patent Ductus Arteriosus in Preterm Infants
by: Belinda Chan, et al.
Published: (2023-12-01)

Patent Ductus Arteriosus (P.D.A.) (An analysis of 37 surgically proved cases)
by: O. J. Rachman, et al.
Published: (2019-09-01)

Transport and Anaesthesia Consideration for Transcatheter Patent Ductus Arteriosus Closure in Premature Infants
by: Tuan Chen Aw, et al.
Published: (2023-09-01)

Paracetamol-responsive patent ductus arteriosus in a late preterm very low birth weight neonate at 4 weeks postnatal age
by: Amitoj Singh Chhina, et al.
Published: (2016-01-01)

Patent Ductus Arteriosus Device Closure with AMPLATZER Duct Occluder-II in a Low Birth Weight Preterm Neonate- First Experience in Pakistan
by: Sana Imtiaz, et al.
Published: (2023-05-01)

Management of Patent Ductus Arteriosus in Premature Infants in 2020
by: Sarah Parkerson, et al.
Published: (2021-02-01)

Correlation between the Closure Time of Patent Ductus Arteriosus in Preterm Infants and Long-Term Neurodevelopmental Outcome
by: Natsumi Kikuchi, et al.
Published: (2024-01-01)

Baby-OSCAR: Outcome after Selective early treatment for Closure of patent ductus ARteriosus in preterm babies—a statistical analysis plan for short-term outcomes
by: Jennifer L. Bell, et al.
Published: (2021-05-01)

Patent ductus arteriosus in preterm infants; experience of a tertiary referral neonatal intensive care unit: prevalence, complications, and management
by: Reem M. Soliman, et al.
Published: (2020-12-01)

Current Controversy on Platelets and Patent Ductus Arteriosus Closure in Preterm Infants
by: Hannes Sallmon, et al.
Published: (2021-02-01)

Myocardial injury and inflammatory response in percutaneous device closures of pediatric patent ductus arteriosus
by: Zeng-Rong Luo, et al.
Published: (2022-05-01)

Efficacy and safety of transcarotid compared to transfemoral approach of patent ductus arteriosus stenting in duct-dependent cyanotic heart disease
by: Made Satria Yudha Dewangga, et al.
Published: (2023-06-01)

The impact of the route of administration on the efficacy and safety of the drug therapy for patent ductus arteriosus in premature infants: a systematic review and meta-analysis
by: Hanwen Luo, et al.
Published: (2024-01-01)

Patent ductus arteriosus with persistent pulmonary artery hypertension after transcatheter closure
by: Feng JQ, et al.
Published: (2016-11-01)

Base excess and hematocrit predict response to indomethacin in very low birth weight infants with patent ductus arteriosus
by: Janardhan Mydam, et al.
Published: (2019-08-01)

The Transcatheter Closure of Patent Ductus Arteriosus in Extremely Low-Birth-Weight Infants: Technique and Results
by: Alban-Elouen Baruteau, et al.
Published: (2023-11-01)

Outcomes of transcatheter closure of patent ductus arteriosus with the off-label use of large occluders (≥16 mm)
by: Kewal Kanabar, et al.
Published: (2020-03-01)

Subaortic membrane with patent ductus arteriosus
by: Nishes Basnet, et al.
Published: (2017-11-01)

Echocardiographic Parameters of Severity in Isolated Neonatal Patent Ductus Arteriosus
by: Baher M. Hanna, et al.
Published: (2021-07-01)

Decreased Incidence of Intraventricular Hemorrhage in Extremely Low Birth Weight Infants Using Customized Circulatory Management to Evaluate the Hemodynamic Change of Patent Ductus Arteriosus
by: Wan-Heng Huang, et al.
Published: (2021-09-01)

Surgical Treatment of Patent Ductus Arteriosus by Combined Ligation and ClippingSomchai Waikittipong
by: Somchai Waikittipong
Published: (2011-02-01)

Which Criteria are More Valuable in Defining Hemodynamic Significance of Patent Ductus Arteriosus in Premature Infants? Respiratory or Echocardiographic?
by: İrfan Oğuz Şahin, et al.
Published: (2017-03-01)

Diameter of the ductus arteriosus as a predictor of patent ductus arteriosus (PDA)
by: Nowak Dariusz, et al.
Published: (2011-08-01)

Konversi Epidural Labor Analgesia (ELA) menjadi Anestesi Epidural untuk Crash Seksio Sesarea pada Pasien Patent Ductus Arteriosus (PDA) dan Pulmonary Hypertension (PH)
by: Yoga Pranata, et al.
Published: (2024-03-01)

Evaluation the Effectiveness of Ibuprofen in Improving Patent Ductus Arteriosus
by: Maryam Beheshtifard, et al.
Published: (2021-09-01)

Patent ductus arteriosus with a rare hand anomaly
by: Y Ramesh Bhat, et al.
Published: (2022-01-01)

Evaluation the Effectiveness of Ibuprofen in Improving Patent Ductus Arteriosus
by: Maryam Beheshtifard, et al.
Published: (2021-09-01)

Safety of single-pulse TMS in two infants with implanted patent ductus arteriosus closure devices
by: Jesse L. Kowalski, et al.
Published: (2020-05-01)

Physiological marker and surgical ligation of patent ductus arteriosus in neonates
by: Behrouz Banieghbal
Published: (2016-01-01)

Late Complication After Transcatheter Closure of Patent Ductus Arteriosus
by: Alessandro Salustri, MD, PhD, et al.
Published: (2019-10-01)

“Clinical Profile of Neonates with Patent Ductus Arteriosus and Factors Predicting Prolonged Paracetamol Treatment and Outcome” – A retrospective Study
by: K Shilpa, et al.
Published: (2021-01-01)

Intravenous Paracetamol and Patent Ductus Arteriosus Closure
by: Herlina Dimiati, et al.
Published: (2020-01-01)

Hemodynamic factors analysis on patent ductus arteriosus (PDA) closure devices /
by: Munder Mustaq Mohammed Azhar, 1994-, author, et al.
Published: (2018)

Hemodynamic factors analysis on patent ductus arteriosus (PDA) closure devices /
by: Munder Mustaq Mohammed Azhar, 1994-, author, et al.
Published: (2018)

Patent ductus arteriosus: peculiarities of early neonatal, postnatal diagnostics, clinical manifestations, treatment and prognosis
by: K.A. Kalashnikova, et al.
Published: (2017-03-01)

Patent ductus arteriosus (PDA): Recent recommendations for to close or not to close
by: Yasemin Ezgi Köstekci, et al.
Published: (2024-03-01)

Percutaneous closure of patent ductus arteriosus with the Nit-Occlud® patent ductus arteriosus device in 268 consecutive cases
by: Andrii V Maksymenko, et al.
Published: (2019-01-01)

Role of Echocardiography in Percutaneous Closure of Patent Ductus Arteriosus
by: Sujata S Alawani, et al.
Published: (2022-01-01)